Dariusz Pawlak

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 52

Top Topics

Venous Thromboembolism

Ankylosing Spondylitis

Patients Undergoing

Chronic Kidney Disease

Top Venues

Journal of clinical medicine

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Magdalena Kopańko, Magdalena Zabłudowska, Dariusz Pawlak, Beata Sieklucka, Anna Krupa, Katarzyna Sokołowska, Marta Ziemińska, Krystyna Pawlak
The Possible Effect of β-Blocker Use on the Circulating MMP-2/TIMP-2 System in Patients with Chronic Kidney Disease on Conservative Treatment. Journal of clinical medicine 13 (7) (2024)
Adam Płoński, Dariusz Pawlak, Adam Filip Płoński, Jerzy Głowiński, Grzegorz Madycki, Krystyna Pawlak
Gray-Scale Median in Patients with Symptomatic and Asymptomatic Carotid Atherosclerosis-Risk Factors and Diagnostic Potential. Biomedicines 12 (7) (2024)
Adam Płoński, Dariusz Pawlak, Adam Filip Płoński, Jerzy Głowiński, Grzegorz Madycki, Krystyna Pawlak
Gray-Scale Median in Patients with Symptomatic and Asymptomatic Carotid Atherosclerosis-Risk Factors and Diagnostic Potential. Biomedicines 12 (7) (2024)
Adam Kern, Tomasz Stompór, Krystian Bojko, Ewa Sienkiewicz, Sebastian Pawlak, Dariusz Pawlak, Grzegorz Poskrobko, Ewa Andrasz, Leszek Gromadziński, Rakesh Jalali, Dariusz Onichimowski, Grażyna Piwko, Artur Zalewski, Jacek Bil
Ten-Year Outcomes in Patients Undergoing Simultaneous Coronary and Renal Angiography-Does Renal Artery Stenosis Matter? Journal of clinical medicine 13 (12) (2024)
Adam Płoński, Dariusz Pawlak, Adam Filip Płoński, Jerzy Głowiński, Grzegorz Madycki, Krystyna Pawlak
Gray-Scale Median in Patients with Symptomatic and Asymptomatic Carotid Atherosclerosis-Risk Factors and Diagnostic Potential. Biomedicines 12 (7) (2024)
Marianna Ciwun, Anna Tankiewicz-Kwedlo, Dariusz Pawlak
Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy. Cancers 16 (6) (2024)
Magdalena Kopańko, Magdalena Zabłudowska, Dariusz Pawlak, Beata Sieklucka, Anna Krupa, Katarzyna Sokołowska, Marta Ziemińska, Krystyna Pawlak
The Possible Effect of β-Blocker Use on the Circulating MMP-2/TIMP-2 System in Patients with Chronic Kidney Disease on Conservative Treatment. Journal of clinical medicine 13 (7) (2024)
Adrian Mor, Anna Tankiewicz-Kwedlo, Marianna Ciwun, Janina Lewkowicz, Dariusz Pawlak
Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders. Cells 13 (15) (2024)
Adam Kern, Tomasz Stompór, Krystian Bojko, Ewa Sienkiewicz, Sebastian Pawlak, Dariusz Pawlak, Grzegorz Poskrobko, Ewa Andrasz, Leszek Gromadziński, Rakesh Jalali, Dariusz Onichimowski, Grażyna Piwko, Artur Zalewski, Jacek Bil
Ten-Year Outcomes in Patients Undergoing Simultaneous Coronary and Renal Angiography-Does Renal Artery Stenosis Matter? Journal of clinical medicine 13 (12) (2024)
Marianna Ciwun, Anna Tankiewicz-Kwedlo, Dariusz Pawlak
Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy. Cancers 16 (6) (2024)
Magdalena Kopańko, Magdalena Zabłudowska, Dariusz Pawlak, Beata Sieklucka, Anna Krupa, Katarzyna Sokołowska, Marta Ziemińska, Krystyna Pawlak
The Possible Effect of β-Blocker Use on the Circulating MMP-2/TIMP-2 System in Patients with Chronic Kidney Disease on Conservative Treatment. Journal of clinical medicine 13 (7) (2024)
Adrian Mor, Anna Tankiewicz-Kwedlo, Marianna Ciwun, Janina Lewkowicz, Dariusz Pawlak
Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders. Cells 13 (15) (2024)
Dariusz Rozkiewicz, Justyna Magdalena Hermanowicz, Iwona Kwiatkowska, Anna Krupa, Dariusz Pawlak
Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials. Molecules (Basel, Switzerland) 28 (5) (2023)
Iwona Kwiatkowska, Justyna Magdalena Hermanowicz, Robert Czarnomysy, Arkadiusz Surażyński, Krystyna Kowalczuk, Joanna Kałafut, Alicja Przybyszewska-Podstawka, Krzysztof Bielawski, Adolfo Rivero-Muller, Mariusz Mojzych, Dariusz Pawlak
Assessment of an Anticancer Effect of the Simultaneous Administration of MM-129 and Indoximod in the Colorectal Cancer Model. Cancers 16 (1) (2023)
Dariusz Rozkiewicz, Justyna Magdalena Hermanowicz, Iwona Kwiatkowska, Anna Krupa, Dariusz Pawlak
Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials. Molecules (Basel, Switzerland) 28 (5) (2023)
Iwona Kwiatkowska, Justyna Magdalena Hermanowicz, Robert Czarnomysy, Arkadiusz Surażyński, Krystyna Kowalczuk, Joanna Kałafut, Alicja Przybyszewska-Podstawka, Krzysztof Bielawski, Adolfo Rivero-Muller, Mariusz Mojzych, Dariusz Pawlak
Assessment of an Anticancer Effect of the Simultaneous Administration of MM-129 and Indoximod in the Colorectal Cancer Model. Cancers 16 (1) (2023)
Julia Nowowiejska, Anna Baran, Justyna Magdalena Hermanowicz, Anna Pryczynicz, Beata Sieklucka, Dariusz Pawlak, Iwona Flisiak
Gasdermin D (GSDMD) Is Upregulated in Psoriatic Skin-A New Potential Link in the Pathogenesis of Psoriasis. International journal of molecular sciences 24 (17) (2023)
Anna Tankiewicz-Kwedlo, Tomasz Lobacz, Leszek Kozlowski, Bogumila Czartoryska-Arlukowicz, Mariusz Koda, Krystyna Pawlak, Robert Czarnomysy, Magdalena Joanna Borkowska, Dariusz Pawlak
ONCOBREAST-TEST Is a Quick Diagnostic, Prognostic and Predictive Method of Response to Systemic Treatment. Cancers 16 (1) (2023)
Tomasz Pawlowski, Krzysztof Malyszczak, Dariusz Pawlak, Małgorzata Inglot, Małgorzata Zalewska, Anna Grzywacz, Marek Radkowski, Tomasz Laskus, Justyna Janocha-Litwin, Dorota Frydecka
HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV). Cells 12 (6) (2023)
Tomasz Pawlowski, Krzysztof Malyszczak, Dariusz Pawlak, Małgorzata Inglot, Małgorzata Zalewska, Anna Grzywacz, Marek Radkowski, Tomasz Laskus, Justyna Janocha-Litwin, Dorota Frydecka
HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV). Cells 12 (6) (2023)
Anna Tankiewicz-Kwedlo, Tomasz Lobacz, Leszek Kozlowski, Bogumila Czartoryska-Arlukowicz, Mariusz Koda, Krystyna Pawlak, Robert Czarnomysy, Magdalena Joanna Borkowska, Dariusz Pawlak
ONCOBREAST-TEST Is a Quick Diagnostic, Prognostic and Predictive Method of Response to Systemic Treatment. Cancers 16 (1) (2023)
Tomasz Pawlowski, Krzysztof Malyszczak, Dariusz Pawlak, Małgorzata Inglot, Małgorzata Zalewska, Anna Grzywacz, Marek Radkowski, Tomasz Laskus, Justyna Janocha-Litwin, Dorota Frydecka
HTR1A, TPH2, and 5-HTTLPR Polymorphisms and Their Impact on the Severity of Depressive Symptoms and on the Concentration of Tryptophan Catabolites during Hepatitis C Treatment with Pegylated Interferon-α2a and Oral Ribavirin (PEG-IFN-α2a/RBV). Cells 12 (6) (2023)
Dariusz Rozkiewicz, Justyna Magdalena Hermanowicz, Iwona Kwiatkowska, Anna Krupa, Dariusz Pawlak
Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials. Molecules (Basel, Switzerland) 28 (5) (2023)
Julia Nowowiejska, Anna Baran, Anna Pryczynicz, Justyna Magdalena Hermanowicz, Beata Sieklucka, Dariusz Pawlak, Iwona Flisiak
Gasdermin E (GSDME)-A New Potential Marker of Psoriasis and Its Metabolic Complications: The First Combined Study on Human Serum, Urine and Tissue. Cells 12 (17) (2023)
Dariusz Rozkiewicz, Justyna Magdalena Hermanowicz, Iwona Kwiatkowska, Anna Krupa, Dariusz Pawlak
Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials. Molecules (Basel, Switzerland) 28 (5) (2023)
Julia Nowowiejska, Anna Baran, Justyna Magdalena Hermanowicz, Beata Sieklucka, Dariusz Pawlak, Iwona Flisiak
Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications. Biomolecules 13 (10) (2023)
Anna Baran, Julia Nowowiejska, Justyna Magdalena Hermanowicz, Beata Sieklucka, Julita Anna Krahel, Paulina Kiluk, Dariusz Pawlak, Iwona Flisiak
The Potential Role of Serum Tau Protein (MAPT), Neuronal Cell Adhesion Molecule (NrCAM) and Neprilysin (NEP) in Neurodegenerative Disorders Development in Psoriasis-Preliminary Results. Journal of clinical medicine 11 (17) (2022)
Julia Nowowiejska, Anna Baran, Justyna Magdalena Hermanowicz, Joanna Mikłosz, Karol Adam Kamiński, Marcin Kondraciuk, Marlena Dubatowka, Dariusz Pawlak, Iwona Flisiak
Angiopoietin-Like 4 (ANGPTL4) in Patients with Psoriasis, Lichen Planus and Vitiligo-A Pilot Study from the Bialystok+ Polish Longitudinal University Study. Metabolites 12 (9) (2022)
Aleksandra Jakimczuk, Bartlomiej Kalaska, Kamil Kaminski, Joanna Miklosz, Shin-Ichi Yusa, Dariusz Pawlak, Krzysztof Szczubiałka, Andrzej Mogielnicki
Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins. Journal of clinical medicine 11 (8) (2022)
Magdalena Massalska, Marzena Ciechomska, Ewa Kuca Warnawin, Tomasz Burakowski, Anna Kornatka, Anna Radzikowska, Dariusz Pawlak, Barbara Muz, Adrianna Loniewska-Lwowska, Andrzej Palucha, Paweł Małdyk, Wlodzimierz Maslinski
Effectiveness of Soluble CTLA-4-Fc in the Inhibition of Bone Marrow T-Cell Activation in Context of Indoleamine 2.3-Dioxygenase (IDO) and CD4 + Foxp3 + Treg Induction. Journal of inflammation research 15 (2022)
Julia Nowowiejska, Anna Baran, Justyna Magdalena Hermanowicz, Beata Sieklucka, Julita Anna Krahel, Paulina Kiluk, Dariusz Pawlak, Iwona Flisiak
Fatty Acid-Binding Protein 7 (FABP-7), Glutamic Acid and Neurofilament Light Chain (NFL) as Potential Markers of Neurodegenerative Disorders in Psoriatic Patients-A Pilot Study. Journal of clinical medicine 11 (9) (2022)
Iwona Kwiatkowska, Justyna Magdalena Hermanowicz, Zaneta Iwinska, Krystyna Kowalczuk, Jolanta Iwanowska, Dariusz Pawlak
Zebrafish-An Optimal Model in Experimental Oncology. Molecules (Basel, Switzerland) 27 (13) (2022)
Jakub Wesolowski, Anna Tankiewicz-Kwedlo, Dariusz Pawlak
Modern Immunotherapy in the Treatment of Triple-Negative Breast Cancer. Cancers 14 (16) (2022)
Marta Ziemińska, Dariusz Pawlak, Beata Sieklucka, Katarzyna Chilkiewicz, Krystyna Pawlak
Vitamin K-Dependent Carboxylation of Osteocalcin in Bone-Ally or Adversary of Bone Mineral Status in Rats with Experimental Chronic Kidney Disease? Nutrients 14 (19) (2022)
Magdalena Massalska, Marzena Ciechomska, Ewa Kuca Warnawin, Tomasz Burakowski, Anna Kornatka, Anna Radzikowska, Dariusz Pawlak, Barbara Muz, Adrianna Loniewska-Lwowska, Andrzej Palucha, Paweł Małdyk, Wlodzimierz Maslinski
Effectiveness of Soluble CTLA-4-Fc in the Inhibition of Bone Marrow T-Cell Activation in Context of Indoleamine 2.3-Dioxygenase (IDO) and CD4 + Foxp3 + Treg Induction. Journal of inflammation research 15 (2022)
Adrian Mor, Anna Tankiewicz-Kwedlo, Dariusz Pawlak
Kynurenines as a Novel Target for the Treatment of Malignancies. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Joanna Miklosz, Bartlomiej Kalaska, Stanislaw Zajaczkowski, Dariusz Pawlak, Andrzej Mogielnicki
Monitoring of Cardiorespiratory Parameters in Rats-Validation Based on Pharmacological Stimulation. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Justyna Swieton, Joanna Miklosz, Shin-Ichi Yusa, Krzysztof Szczubiałka, Dariusz Pawlak, Andrzej Mogielnicki, Bartlomiej Kalaska
Reversal Activity and Toxicity of Heparin-Binding Copolymer after Subcutaneous Administration of Enoxaparin in Mice. International journal of molecular sciences 22 (20) (2021)
Zuzanna Rzepka, Jakub Rok, Mateusz Maszczyk, Artur Beberok, Justyna Magdalena Hermanowicz, Dariusz Pawlak, Dorota Gryko, Dorota Wrześniok
Response of Human Glioblastoma Cells to Vitamin B12 Deficiency: A Study Using the Non-Toxic Cobalamin Antagonist. Biology 10 (1) (2021)
Joanna Miklosz, Bartlomiej Kalaska, Piotr Podlasz, Małgorzata Chmielewska-Krzesińska, Miłosz Andrzej Zajączkowski, Adam Kosiński, Dariusz Pawlak, Andrzej Mogielnicki
Cardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent Models. Pharmaceutics 13 (3) (2021)
Małgorzata Kiluk, Janina Lewkowicz, Dariusz Pawlak, Anna Tankiewicz-Kwedlo
Crosstalk between Tryptophan Metabolism via Kynurenine Pathway and Carbohydrate Metabolism in the Context of Cardio-Metabolic Risk-Review. Journal of clinical medicine 10 (11) (2021)
Justyna Magdalena Hermanowicz, Krystyna Pawlak, Beata Sieklucka, Robert Czarnomysy, Iwona Kwiatkowska, Adam Kazberuk, Arkadiusz Surazynski, Mariusz Mojzych, Dariusz Pawlak
MM-129 as a Novel Inhibitor Targeting PI3K/AKT/mTOR and PD-L1 in Colorectal Cancer. Cancers 13 (13) (2021)
Iwona Kwiatkowska, Justyna Magdalena Hermanowicz, Alicja Przybyszewska-Podstawka, Dariusz Pawlak
Not Only Immune Escape-The Confusing Role of the TRP Metabolic Pathway in Carcinogenesis. Cancers 13 (11) (2021)
Justyna Magdalena Hermanowicz, Bartlomiej Kalaska, Krystyna Pawlak, Beata Sieklucka, Joanna Miklosz, Mariusz Mojzych, Dariusz Pawlak
Preclinical Toxicity and Safety of MM-129-First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer. Pharmaceutics 13 (8) (2021)
Adrian Mor, Anna Tankiewicz-Kwedlo, Anna Krupa, Dariusz Pawlak
Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders. Cells 10 (7) (2021)
Krystyna Pawlak, Beata Sieklucka, Dariusz Pawlak
Paracrine Kynurenic Pathway Activation in the Bone of Young Uremic Rats Can Antagonize Anabolic Effects of PTH on Bone Turnover and Strength through the Disruption of PTH-Dependent Molecular Signaling. International journal of molecular sciences 22 (12) (2021)
Iwona Kwiatkowska, Justyna Magdalena Hermanowicz, Michal Mysliwiec, Dariusz Pawlak
Oxidative Storm Induced by Tryptophan Metabolites: Missing Link between Atherosclerosis and Chronic Kidney Disease. Oxidative medicine and cellular longevity 2020 (2020)
Bartlomiej Kalaska, Joanna Miklosz, Kamil Kaminski, Justyna Swieton, Aleksandra Jakimczuk, Shin-Ichi Yusa, Dariusz Pawlak, Maria Nowakowska, Krzysztof Szczubiałka, Andrzej Mogielnicki
Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats. The Journal of pharmacology and experimental therapeutics 373 (1) (2020)
Adrian Mor, Bartlomiej Kalaska, Dariusz Pawlak
Kynurenine Pathway in Chronic Kidney Disease: What's Old, What's New, and What's Next? International journal of tryptophan research : IJTR 13 (2020)
Adrian Mor, Krystyna Pawlak, Bartlomiej Kalaska, Tomasz Domaniewski, Beata Sieklucka, Marta Zieminska, Bogdan Cylwik, Dariusz Pawlak
Modulation of the Paracrine Kynurenic System in Bone as a New Regulator of Osteoblastogenesis and Bone Mineral Status in an Animal Model of Chronic Kidney Disease Treated with LP533401. International journal of molecular sciences 21 (17) (2020)
Anna Tankiewicz-Kwedlo, Justyna Magdalena Hermanowicz, Krystyna Pawlak, Robert Czarnomysy, Krzysztof Bielawski, Izabela Prokop, Dariusz Pawlak
Erythropoietin Intensifies the Proapoptotic Activity of LFM-A13 in Cells and in a Mouse Model of Colorectal Cancer. International journal of molecular sciences 19 (4) (2018)
Tomasz W Kamiński, Krystyna Pawlak, Małgorzata Karbowska, Michał Myśliwiec, Dariusz Pawlak
Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease. BMC nephrology 18 (1) (2017)